Typefaces

Myriad Genetics’ Board Member, S. Louise Phanstiel, Recognized by WomenInc. Magazine in 2019 List of Most Influential Corporate Directors

Retrieved on: 
Thursday, December 19, 2019

Magazines 2019 Most Influential Corporate Board Directors list.

Key Points: 
  • Magazines 2019 Most Influential Corporate Board Directors list.
  • We congratulate Louise for this well-deserved acknowledgment of her leadership and many contributions to our success, saidMark C. Capone, president and CEO of Myriad Genetics.
  • At Myriad, we believe an inclusive work environment is one of the reasons we have been so successful through the years.
  • In 2018 and 2019, Myriad was recognized by the Women Tech Council as one of the best workplaces for women in the United States.

Avenir LNG Limited Appoints Milorad Doljanin as CEO

Retrieved on: 
Wednesday, December 4, 2019

London, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Avenir LNG Limited (NOTC: AVENIR) announced today that Milorad Doljanin will assume the role of Chief Executive Officer with effect December 13th, 2019.

Key Points: 
  • London, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Avenir LNG Limited (NOTC: AVENIR) announced today that Milorad Doljanin will assume the role of Chief Executive Officer with effect December 13th, 2019.
  • Mr Doljaninsucceeds Andrew Pickering, who will retire as CEO of Avenir LNG Limited on December 13th, 2019.
  • Mr Pickering has spent almost 40 years with Stolt-Nielsen Limited, the last five years heading the LNG group, which led to the launch of Avenir LNG Limited in 2018.
  • About Avenir LNG Limited: Avenir LNG supplies small-scale LNG to the marine bunkering, off-grid industries, power generation and transport fuel sectors.Avenir LNG is one of the leading providers of small-scale LNG solutions; working with local partners and end users to develop the infrastructure necessary to unlock new markets for natural gas.

Redfin Survey: Millennials Still Want Single-Family Homes, Even if it Means a Long Commute

Retrieved on: 
Thursday, November 21, 2019

The triplex is smaller, but meets your space needs, and has a shared backyard and significantly shorter commute.

Key Points: 
  • The triplex is smaller, but meets your space needs, and has a shared backyard and significantly shorter commute.
  • 89% of homebuyers would prefer a single-family home with a backyard over a unit in a triplex with a shorter commute.
  • Among millennials, 93% would choose a single-family home, as would the vast majority of all other age groups over 25.
  • The price premium for single-family homes over condos is declining in expensive areas and increasing in affordable inland areas.

Sterling Lexicon Enhances Small Shipment Program with Sterling Xpress

Retrieved on: 
Tuesday, November 19, 2019

JACKSONVILLE, Fla., Nov. 19, 2019 /PRNewswire/ -- Sterling Lexicon, a leading provider of global relocation services, has upgraded its popular household goods small shipment solution with the introduction of Sterling Xpress.

Key Points: 
  • JACKSONVILLE, Fla., Nov. 19, 2019 /PRNewswire/ -- Sterling Lexicon, a leading provider of global relocation services, has upgraded its popular household goods small shipment solution with the introduction of Sterling Xpress.
  • The small shipment solution was originally introduced in 2017 to overcome industry challenges, such as diminishing capacity, driver shortages, and decreasing shipment sizes.
  • By combining the convenience of full-service moving with the speed and agility of containerized shipping, Sterling Lexicon has reduced claims and costs while enhancing the employee experience.
  • "Our customers are raving about the program offering," said Rob Vespa, senior vice president of move management for Sterling Lexicon.

Pawar Law Group Reminds Investors of NOV. 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. – MYGN

Retrieved on: 
Wednesday, November 13, 2019

NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) from September 2, 2016 through August 13, 2019 inclusive (the Class Period).

Key Points: 
  • NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) from September 2, 2016 through August 13, 2019 inclusive (the Class Period).
  • The lawsuit seeks to recover damages for Myriad Genetics, Inc. investors under the federal securities laws.
  • If you wish to serve as lead plaintiff, you must move the Court no later than November 26, 2019.
  • To express an interest in the class action, go http://pawarlawgroup.com/cases/myriad-genetics-inc/ or call Vik Pawar, Esq.

Myriad Genetics to Present at the 2019 Stephens Nashville Investment Conference

Retrieved on: 
Thursday, November 7, 2019

SALT LAKE CITY, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that Bryan Riggsbee, CFO, is scheduled to present at the Stephens Nashville Investment Conference at 12:15 p.m. EST on November 13, 2019, in Nashville.

Key Points: 
  • SALT LAKE CITY, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that Bryan Riggsbee, CFO, is scheduled to present at the Stephens Nashville Investment Conference at 12:15 p.m. EST on November 13, 2019, in Nashville.
  • Myriad Genetics, Inc., is a leading precision medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics.
  • For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com .
  • Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice HRD, EndoPredict, Vectra, GeneSight, riskScore Prolaris, ForeSight and Prequel are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries.

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Myriad Genetics, Inc.– MYGN

Retrieved on: 
Thursday, November 7, 2019

NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) from September 2, 2016 through August 13, 2019 inclusive (the Class Period).

Key Points: 
  • NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) from September 2, 2016 through August 13, 2019 inclusive (the Class Period).
  • The lawsuit seeks to recover damages for Myriad Genetics, Inc. investors under the federal securities laws.
  • To join the class action, go http://pawarlawgroup.com/cases/myriad-genetics-inc/ or call Vik Pawar, Esq.
  • toll-free at 888-589-9804 or email [email protected] for information on the class action.

Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update

Retrieved on: 
Thursday, November 7, 2019

THE WOODLANDS, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended September 30, 2019.

Key Points: 
  • THE WOODLANDS, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended September 30, 2019.
  • Sanofi continues to coordinate with Lexicon in the transition of responsibility for ongoing clinical studies and other activities.
  • Lexicon management will hold a live conference call and webcast today at 8:00 am EST / 7:00 am CST to review its financial and operating results and to provide a general business update.
  • Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

Type Expertise at the Core of New Services From Monotype

Retrieved on: 
Thursday, October 24, 2019

These new services from the Monotype Studio consist of consulting time with some of the worlds most renowned type designers, font engineers, quality assurance and script experts.

Key Points: 
  • These new services from the Monotype Studio consist of consulting time with some of the worlds most renowned type designers, font engineers, quality assurance and script experts.
  • With the new service, Monotype can help guide brands to unify visual and written expression across markets, messaging, mediums and products.
  • Earlier this year, Monotype worked with Alibaba to create a global typeface, Alibaba Sans , which spans 172 different languages.
  • For more information about the professional services offered by the Monotype Studio, visit here , or contact Monotype to learn more.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sundial, electroCore, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, October 16, 2019

reminds investors that class action lawsuits have been commenced on behalf of stockholders of Sundial Growers, Inc. (NASDAQ: SNDL), electroCore, Inc. (NASDAQ:ECOR), Tencent Music Entertainment Group (NYSE: TME), and Myriad Genetics, Inc. (NASDAQ: MYGN).

Key Points: 
  • reminds investors that class action lawsuits have been commenced on behalf of stockholders of Sundial Growers, Inc. (NASDAQ: SNDL), electroCore, Inc. (NASDAQ:ECOR), Tencent Music Entertainment Group (NYSE: TME), and Myriad Genetics, Inc. (NASDAQ: MYGN).
  • Class Period: Securities purchased pursuant to and/or traceable to the companys August 1, 2019 initial public offering (IPO).
  • Due to quality issues, Zenabis had to return or reject a total of 554 kg of cannabis from a third-party.
  • For more information on the Myriad Genetics class action go to: https://bespc.com/MYGN
    Bragar Eagel & Squire, P.C.